Edwards Lifesciences this evening reported Street-beating Q2 results, upping the lower end of its full-year sales guidance.

GE HealthCare (Nasdaq: GEHC) today announced the commercial launch of its advanced floor-mounted digital X-ray system.

The FDA today issued a notice warning of a recall of arterial perfusion cannula devices made by Edwards Lifesciences (NYSE:EW ...

Integer (NYSE: ITGR) shares took a hit today on second-quarter results that were mixed compared to the consensus forecast.

Bloomberg reports that brain-computer interface (BCI) maker Neuralink expects annual revenues to total at least $1 billion ...

According to a news release, Osstem is the market-leading provider of dental implants in China. Under the agreement, it has ...

Philips announced today that it entered into a collaboration with Epic to integrate cardiac ambulatory monitoring and ...

NeuroOne Medical Technologies this week announced its patent covering novel manufacturing steps for neural probe devices ...

Neuros Medical announced today that the first commercial patient in the U.S. successfully received an FDA-approved Altius ...

Boston Scientific expects adjusted EPS to range between $2.95 and $2.99 for the full year. That marks a significant rise from ...

Philips (NYSE: PHG) announced today that it received FDA 510(k) clearance for the latest UroNav image-guided navigation ...

Elekta announced today that it received FDA 510(k) clearance to expand indications for its Leksell Gamma Knife radiosurgery ...